NeuroCOV Partners Advance Exploitation Strategy in Dedicated Webinar

On 4 December 2025, NeuroCOV partners convened for a dedicated webinar on the exploitation strategy, focusing on Key Exploitable Result (KER) 1: “Risk Factors for NeuroCOVID manifestation, severity and duration.”

The consortium-wide webinar opened with a general introduction by EURICE, followed by a research presentation by PhD candidate Angele Ahebla, which offered fresh insights into ongoing scientific work. Building on this, Klara Schneider from EURICE moderated a productive discussion among all partners contributing to KER 1, including the German Center for Neurodegenerative Diseases, Human Technopole, the University of Milan, the Institute for Molecular Medicine Finland, KU Leuven, and KER 1 lead Umeå University. In the final segment, Klara Schneider presented sustainability strategies and planning tools designed to support exploitation efforts across additional KERs.

The webinar marked an important step toward ensuring that NeuroCOV outcomes can generate long-term value for research, healthcare, and society.